These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35708432)

  • 1. Uptake and usage of proguanil as malaria chemoprophylaxis and the socio-economic determinants of proguanil usage in children with sickle cell anemia in Benin City.
    Enato IG; Odunvbun ME
    Niger J Clin Pract; 2022 Jun; 25(6):903-908. PubMed ID: 35708432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monthly sulphadoxine-pyrimethamine combination versus daily proguanil for malaria chemoprophylaxis in sickle cell disease: a randomized controlled study at the Jos University Teaching Hospital.
    Dawam JA; Madaki JKA; Gambazai AA; Okpe ES; Lar-ndam N; Onu A; Gyang M
    Niger J Med; 2016; 25(2):119-27. PubMed ID: 29944308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Randomized Trial to Compare the Safety, Tolerability, and Effectiveness of 3 Antimalarial Regimens for the Prevention of Malaria in Nigerian Patients With Sickle Cell Disease.
    Olaosebikan R; Ernest K; Bojang K; Mokuolu O; Rehman AM; Affara M; Nwakanma D; Kiechel JR; Ogunkunle T; Olagunju T; Murtala R; Omefe P; Lambe T; Bello S; Ibrahim O; Olorunsola B; Ojuawo A; Greenwood B; Milligan P
    J Infect Dis; 2015 Aug; 212(4):617-25. PubMed ID: 25701866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Molecular Markers of Plasmodium Falciparum Resistance to Proguanil and Pyrimethamine in Children with Haemoglobin Phenotypes SS and AA in Benin City, Nigeria.
    Enato IG; Sadoh AE; Ibadin OM; Odunvbun ME
    West Afr J Med; 2021 Dec; 38(12):1183-1189. PubMed ID: 35037448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and effectiveness of antimalarial therapy in sickle cell disease: a systematic review and network meta-analysis.
    Frimpong A; Thiam LG; Arko-Boham B; Owusu EDA; Adjei GO
    BMC Infect Dis; 2018 Dec; 18(1):650. PubMed ID: 30541465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization patterns of malaria chemoprophylaxis among Tanzanian children attending sickle cell clinic in Dar es Salaam tertiary hospitals.
    Ndegeulaya EJ; Bwire GM; Sangeda RZ; Mloka D; Tungaraza F; Kahere AS; Manyaki FF; Felician FF; Kilonzi M; Mikomangwa WP; Mlyuka HJ; Marealle AI; Mutagonda R; Mwita L; Mwambete KD
    Malar J; 2019 Dec; 18(1):393. PubMed ID: 31796035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydroartemisinin-piperaquine or sulphadoxine-pyrimethamine for the chemoprevention of malaria in children with sickle cell anaemia in eastern and southern Africa (CHEMCHA): a protocol for a multi-centre, two-arm, double-blind, randomised, placebo-controlled superiority trial.
    Nkosi-Gondwe T; Robberstad B; Opoka R; Kalibbala D; Rujumba J; Galileya LT; Akun P; Nambatya W; Ssenkusu J; TerKuile F; Phiri K; Idro R
    Trials; 2023 Apr; 24(1):257. PubMed ID: 37016392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asymptomatic malaria parasitaemia in sickle-cell disease patients: how effective is chemoprophylaxis?
    Kotila R; Okesola A; Makanjuola O
    J Vector Borne Dis; 2007 Mar; 44(1):52-5. PubMed ID: 17378217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malaria chemoprophylaxis in sickle cell disease.
    Oniyangi O; Omari AA
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31681984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative benefit of malaria chemoprophylaxis modelled in United Kingdom travellers.
    Toovey S; Nieforth K; Smith P; Schlagenhauf P; Adamcova M; Tatt I; Tomianovic D; Schnetzler G
    Travel Med Infect Dis; 2014; 12(6 Pt B):726-32. PubMed ID: 25443997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised trial of alternative malaria chemoprophylaxis strategies among pregnant women in Kigoma, Tanzania: II. Results from baseline studies.
    Mnyika SK; Kabalimu TK; Mbaruku G; Masisila R; Mpanju-Shumbusho W
    East Afr Med J; 2000 Feb; 77(2):105-10. PubMed ID: 10774084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presumptive treatment with sulphadoxine-pyrimethamine versus weekly chloroquine for malaria prophylaxis in children with sickle cell anaemia in Uganda: a randomized controlled trial.
    Nakibuuka V; Ndeezi G; Nakiboneka D; Ndugwa CM; Tumwine JK
    Malar J; 2009 Oct; 8():237. PubMed ID: 19852829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-free Holidays: Compliance, Tolerability, and Acceptability of a 3-Day Atovaquone/Proguanil Schedule for Pretravel Malaria Chemoprophylaxis in Australian Travelers.
    Lau CL; Ramsey L; Mills LC; Furuya-Kanamori L; Mills DJ
    Clin Infect Dis; 2019 Jun; 69(1):137-143. PubMed ID: 30281083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent gross splenomegaly in Nigerian patients with sickle cell anaemia: relationship to malaria.
    Adekile AD; Adeodu OO; Jeje AA; Odesanmi WO
    Ann Trop Paediatr; 1988 Jun; 8(2):103-7. PubMed ID: 2456725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of pyrimethamine versus proguanil in malarial chemoprophylaxis in children with sickle cell disease: a randomized, placebo-controlled, open-label study.
    Eke FU; Anochie I
    Curr Ther Res Clin Exp; 2003 Sep; 64(8):616-25. PubMed ID: 24944408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Well-tolerated chemoprophylaxis uniformly prevented Swedish soldiers from Plasmodium falciparum malaria in Liberia, 2004-2006.
    Andersson H; Askling HH; Falck B; Rombo L
    Mil Med; 2008 Dec; 173(12):1194-8. PubMed ID: 19149338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised trial of alternative malaria chemoprophylaxis strategies among pregnant women in Kigoma, Tanzania: I. Rationale and design.
    Mnyika KS; Kabalimu TK; Rukinisha K; Mpanju-Shumbusho W
    East Afr Med J; 2000 Feb; 77(2):98-104. PubMed ID: 10774083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The conundrum of malaria chemoprophylaxis.
    Shanks D
    J Travel Med; 2016 Jun; 23(6):. PubMed ID: 27694470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress toward elimination of malaria in Nigeria: uptake of artemisinin-based combination therapies for the treatment of malaria in households in Benin City.
    Akoria OA; Arhuidese IJ
    Ann Afr Med; 2014; 13(3):104-13. PubMed ID: 24923369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Questionnaire-based analysis of atovaquone-proguanil compared with mefloquine in the chemoprophylaxis of malaria in non-immune Japanese travelers.
    Kato T; Okuda J; Ide D; Amano K; Takei Y; Yamaguchi Y
    J Infect Chemother; 2013 Feb; 19(1):20-3. PubMed ID: 22740189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.